| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/21/2009 | EP2016942A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 01/21/2009 | EP2016079A1 Polymorphs |
| 01/21/2009 | EP2016076A2 Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof |
| 01/21/2009 | EP2016071A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/21/2009 | EP2016063A1 Thiazole derivatives as inhibitors of p13 kinase |
| 01/21/2009 | EP2016048A1 A crystalline form b4 of atorvastatin magnesium and a process thereof |
| 01/21/2009 | EP2016047A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 01/21/2009 | EP2015769A2 Pharmaceutical compositions of hglp-1, exendin-4 and analogs thereof |
| 01/21/2009 | EP2015754A2 Uses of dpp-iv inhibitors |
| 01/21/2009 | EP2015744A2 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle |
| 01/21/2009 | EP2015742A2 Reducing risk of type 2 diabetes (t2d) |
| 01/21/2009 | EP1846410B1 Dihydroquinazolinones as 5ht modulators |
| 01/21/2009 | EP1569680B1 Treatment of diabetes |
| 01/21/2009 | EP1549655B1 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
| 01/21/2009 | EP1531816B1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
| 01/21/2009 | EP1506228B1 Role of p62 in aging-related disease |
| 01/21/2009 | EP1501791B1 Amino acid analogues |
| 01/21/2009 | CN101351462A 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1(VR1) activity |
| 01/21/2009 | CN101351209A Pharmaceutical use of substituted amides |
| 01/21/2009 | CN101348482A 3-amido-4-indole maleimide compound, preparation and use thereof |
| 01/21/2009 | CN101348477A Novel pravastatin lactone crystal form |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101348433A 4-alkoxy-coumarin fatty acid ester, synthetic method and use |
| 01/21/2009 | CN101347579A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347578A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347576A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347572A Medicament for treating diabetes and preparation method |
| 01/21/2009 | CN101347556A Composition beneficial to cardio-cerebrovascular |
| 01/21/2009 | CN101347553A Medicament for treating hyperlipemia |
| 01/21/2009 | CN101347552A Fumigating agent for reducing fat and whitening skin and formulation and use method |
| 01/21/2009 | CN101347545A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347543A Chinese medicine compound and preparation method thereof |
| 01/21/2009 | CN101347530A Oral liquid for regulating blood fat and blood sugar |
| 01/21/2009 | CN101347529A Compound dual-purpose natto capsules as medicine or food and preparation thereof |
| 01/21/2009 | CN101347516A Method for preparing total free anthraquinones extract from rhubarb |
| 01/21/2009 | CN101347511A Medicament composition with function for reducing blood sugar |
| 01/21/2009 | CN101347495A Preparation of Glabridin dispersible tablets and use of the tablets in reducing blood sugar as medicament active composition |
| 01/21/2009 | CN101347486A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347485A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/21/2009 | CN101347466A Capsules containing Ganoderma lucidum and ostrich bones as well as organs |
| 01/21/2009 | CN101347464A Health products capable of reducing blood sugar and method of preparing the same |
| 01/21/2009 | CN101347440A Use of ginseng saponin Re for treating diabetes and metabolism syndrome |
| 01/21/2009 | CN101347428A 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical compositions comprising the same |
| 01/21/2009 | CN101347422A Uses of salvianolic acid A in preventing and/or treating diabetes and complication |
| 01/21/2009 | CN101347419A Stable state vitamin K3and method of preparing the same |
| 01/21/2009 | CN101347414A Divisible galenical preparation form capable of controlling release of active ingredient |
| 01/21/2009 | CN101347240A Health food |
| 01/21/2009 | CN101347235A Cicer arietinum lipid-lowering nourishing powder and method of preparing the same |
| 01/21/2009 | CN101347232A Method for preparing nourishing type fat-reducing pressed candy as well as use |
| 01/21/2009 | CN101347171A Freezing beverage containing chrysanthemum and method of preparing the same |
| 01/21/2009 | CN101347168A Freezing beverage containing ginger sugar juice and method of preparing the same |
| 01/21/2009 | CN100453533C Acceptor excitant of a class of pancreas hyperglycemia peptide-1, preparation method and usage |
| 01/21/2009 | CN100453115C Self-emulsifying agglomerant of oral polypeptide medicine |
| 01/21/2009 | CN100453105C Composition with catharsis and toxin expelling, fat reducing and weight reducing function and preparing method |
| 01/21/2009 | CN100453083C Dextran iron dispersing agent and its prepn. method |
| 01/21/2009 | CN100453078C Method for treating primary insomnia |
| 01/21/2009 | CN100452984C Aimal growth regulating composition and its prepn and use |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479501 Heteroaryl-cyclic acetals |
| 01/20/2009 | CA2517245C Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 01/20/2009 | CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same |
| 01/20/2009 | CA2465738C Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 01/20/2009 | CA2383916C Dispersion formulations containing lipase inhibitors |
| 01/20/2009 | CA2366268C Pharmaceutical compositions for cns and other disorders |
| 01/20/2009 | CA2295599C Novel heterocyclic analogs of diphenylethylene compounds |
| 01/20/2009 | CA2271693C Guanylhydrazones useful for treating diseases associated with t cell activation |
| 01/20/2009 | CA2261040C Pharmaceutical composition comprising combination useful for treatment or prevention of arteriosclerosis or xanthoma |
| 01/15/2009 | WO2009009173A2 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/15/2009 | WO2009008991A2 Dna-pkcs modulates energy regulation and brain function |
| 01/15/2009 | WO2009008480A1 Crosslinked polyallylamine or acid addition salt thereof, and use thereof for medical purposes |
| 01/15/2009 | WO2009008318A1 Electrolytically reduced water, hot water for bathing, and method for suppression of lumpy fat |
| 01/15/2009 | WO2009007697A1 New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabidivarin |
| 01/15/2009 | WO2009007412A2 Age deglycation |
| 01/15/2009 | WO2009007411A2 Inhibition of age formation |
| 01/15/2009 | WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/15/2009 | WO2008142460A3 New herbal composition for prevention and treatmant of diabetes melitusa of type (i) and type (ii) |
| 01/15/2009 | WO2008135661A3 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
| 01/15/2009 | WO2008116913A3 Peptide compounds with transient biodegradable pegylation |
| 01/15/2009 | WO2008087190A3 Use of peptides in combination with surgical intervention for the treatment of obesity |
| 01/15/2009 | WO2008065397A3 Assay |
| 01/15/2009 | WO2008064756A3 Use of substances reducing cellular glutathione content for producing a medicament for treating t-cell mediated autoimmune diseases |
| 01/15/2009 | US20090018413 Implantable medical device for diagnostic sensing |
| 01/15/2009 | US20090018331 Condensed imidazole derivatives |
| 01/15/2009 | US20090018210 A Method for Promoting Fat Degradation |
| 01/15/2009 | US20090018208 Novel Succinate Salt of O-Desmethyl-Venlafaxine |
| 01/15/2009 | US20090018199 Methods of Administering 3, 3, 14, 14 Tetramethyl Hexadecane 1, 16 Dioic Acid |
| 01/15/2009 | US20090018196 Food composition comprising amino acids |
| 01/15/2009 | US20090018183 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/15/2009 | US20090018181 Drug composition for prevention or inhibition of advance of diabetic complication |
| 01/15/2009 | US20090018159 Treatment of Diabetes |
| 01/15/2009 | US20090018157 Chemical compounds |
| 01/15/2009 | US20090018151 Topical Treatment of Peripheral diabetic complications |
| 01/15/2009 | US20090018141 Kinase inhibitors, compositions thereof, and methods of use therewith |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018132 Substituted Heterocyclic Ethers and Their Use in CNS Disorders |
| 01/15/2009 | US20090018114 Novel compounds as cannabinoid receptor ligands |
| 01/15/2009 | US20090018092 Reducing Nephropathy with Inhibitors of Soluble Epoxide Hydrolase and Epoxyeicosanoids |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |